Amarantus Bioscience Holdings Inc (AMBS)

[WarpCore61]

Key words in Jason's new Seeking Alpha article...

The good thing is that all this new cash comes with no new shares being input into our valuation model. With the stock currently trading at $0.10 per share, well above the warrant strike price of $0.06 per share, we had already included these warrants in our fully diluted share count used in our discounted cash flow (DCF) valuation model. This is how we calculated a target price of $0.25 per share. However, we did not include the cash from the warrants in our model. We believe this is the most prudent and conservative way to value companies.

Take it from a trusted source, an analyst who can do real math, unlike some here who believe today's news constitutes additional dilution. IT DOES NOT.